Results 21 to 30 of about 2,672,729 (207)

Neuromyelitis Optica Spectrum Disorder

open access: yesCureus, 2023
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune condition characterized by recurrent episodes of optic neuritis (ON) and transverse myelitis. This case report aims to highlight the importance of considering atypical presentations of NMOSD when confronted with MRI-detected Wernicke's encephalopathy.
Cazzaniga, Juliana   +5 more
openaire   +2 more sources

Accelerating clinical research in neuromyelitis optica spectrum disorders [PDF]

open access: yes, 2021
Neuromyelitis optica spectrum disorders are rare relapsing inflammatory central nervous system diseases with a heterogenous immunological and clinical spectrum.
Oertel, Frederike C., Paul, Friedemann
core   +3 more sources

Neuromyelitis optica spectrum disorders and pregnancy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
Neuromyelitis optica spectrum diseases (NMOSDs) is an autoimmune disease of central nervous system, which occurs frequently in women of childbearing age. NMOSDs may affect pregnancy planning and fertility, and the effect on pregnancy outcome is not clear.
LIU Qiang, ZHANG Qing, QUAN Chao
doaj   +1 more source

Treatment of Neuromyelitis Optica Spectrum Disorders [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system (CNS) inflammatory disorder that can lead to serious disability and mortality. Females are predominantly affected, including those within the reproductive age. Most patients develop relapsing attacks of optic neuritis; longitudinally extensive transverse myelitis ...
Chan, Koon-Ho, Lee, Chi-Yan
openaire   +2 more sources

Neuromyelitis optica spectrum disorder with AQP4‐IgG presenting as area postrema syndrome and progressing to myelitis: A rare case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Neuromyelitis optica spectrum disorders can less commonly present with area postrema syndrome progressing to myelitis. Management involves intravenous glucocorticoids, plasma exchange, and preventive immunotherapy.
Preethi Jagannath   +6 more
doaj   +1 more source

Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy–Case Report [PDF]

open access: yes, 2023
A 60-year-old white woman presented to the emergency department with painless decrease of visual acuity in the left eye (LE). The diagnosis of a non-arteritic anterior ischemic optic neuropathy in the LE was established based on the clinical picture and ...
Lech Sedlak   +2 more
core   +1 more source

Research progress of neuromyelitis optica spectrum disorders: Chinese scholars' reports published abroad

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2016
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of central nervous system (CNS), characterized by severe optic neuritis (ON) and transverse myelitis (TM). Since the discovery of NMO-immunoglobulin G (NMO-IgG), the definition of NMO
Jie-xi WEN   +3 more
doaj   +1 more source

Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome as an Initial Manifestation [PDF]

open access: yes, 2020
A 25-year-old woman was admitted to our hospital due to tonic convulsion with severe headache after having experienced symptoms of nausea and vomiting for a month.
Tateishi, Yohei   +12 more
core   +1 more source

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients [PDF]

open access: yes, 2012
BACKGROUND: The diagnostic and pathophysiological relevance of antibodies to aquaporin-4 (AQP4-Ab) in patients with neuromyelitis optica spectrum disorders (NMOSD) has been intensively studied. However, little is known so far about the clinical impact of
Jarius Sven   +269 more
core   +2 more sources

Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab [PDF]

open access: yes, 2009
In neuromyelitis optica (NMO), the monoclonal B-cell antibody rituximab is a therapeutic option. Little is known about the course of NMO and the safety of rituximab during pregnancy.
Hohlfeld, R.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy